Page 188 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 188

178        ELECTROLYTE DISORDERS


            should be given a calcium-restricted diet because      2. Abrams KL. Hypocalcemia associated with administration
            increased intestinal absorption of calcium contributes   of sodium bicarbonate for salicylate intoxication in a cat.
            substantially to the development of hypercalcemia in     J Am Vet Med Assoc 1987;191:235–6.
                                                                   3. Adamantos S, Boag A. Total and ionised calcium
            hypervitaminosis D.
                                                                     concentrations in dogs with hypoadrenocorticism. Vet Rec
               Patients that maintain serum iCa concentrations in the  2008;163(1):25–6.
            target zone are often managed successfully for years.  4. Adami S, Zamberlan N. Adverse effects of bisphosphonates;
            Twenty-fourof25 dogs withprimaryhypoparathyroidism       a comparative review. Drug Saf 1996;14:158–70.
            were managed successfully for more than 5 years, 179  and  5. Adams JS, Sharma OP, Diz MM, et al. Ketoconazole
                                                                     decreases the serum 1,25-dihydroxyvitamin D and cal-
            long-term management was successful in a small number    cium concentration in sarcoidosis-associated hypercalce-
            of cats. 444  Patients that develop episodic or prolonged  mia. J Clin Endocrinol Metab 1990;70:1090–5.
            hypercalcemia during treatment have a poor prognosis.  6. Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus
            Management with calcitriol is easier and more successful  injection versus continuous infusion of furosemide in nor-
                                                                     mal  adult  greyhound  dogs.  J  Vet  Intern  Med
            in inducing and maintaining serum iCa concentrations
                                                                     2003;17:632–6.
            in the target zone than are older therapeutic approaches.  7. Adler AJ, Ferran N, Berlyne GM. Effect of inorganic phos-
               Hypercalciuria, nephrocalcinosis, urolithiasis, and   phate on serum ionized calcium concentration in vitro: a
            reduced renal function have occurred in humans treated   reassessment of the “trade-off hypothesis.” Kidney Int
            for chronic hypoparathyroidism. 232,572,616  As many as  1985;28:932–5.
                                                                   8. Almaden Y, Canalejo A, Ballesteros E, et al. Regulation of
            80% of human patients treated for 2 years or longer have  arachidonic acid production by intracellular calcium in
            decreased creatinine clearance. 616  These abnormalities  parathyroid cells: effect of extracellular phosphate. J Am
            can be attributed to episodes of hypercalcemia and       Soc Nephrol 2002;13:693–8.
            hyperphosphatemia and to hypercalciuria that occurs in  9. Almaden Y, Felsenfeld AJ, Rodriguez M, et al. Prolifera-
            the absence of the actions of PTH on the renal tubules.  tion in hyperplastic human and normal rat parathyroid
            In the absence of PTH, hypercalciuria occurs more readily  glands: role of phosphate, calcitriol, and gender. Kidney
                                                                     Int 2003;64:2311–7.
            at all serum iCa concentrations and is especially severe as  10. Almirall J, Lopez T, Vallve M, et al. Safety and efficacy of
            iCa concentrations approach the normal range, which      sevelamer in the treatment of uncontrolled hyperpho-
            increases the filtered load of calcium. Nephrocalcinosis,  sphataemia of haemodialysis patients. Nephron Clin Pract
            reduced renal function, and CRF have also been           2004;97:c17–22.
                                                                  11. Amin M, Fawzy A, Hamid MA, et al. Pulmonary hyper-
            suspected in veterinary patients receiving long-term treat-
                                                                     tension in patients with chronic renal failure: role of para-
            ment for hypoparathyroidism, but the risk for these      thyroid hormone and pulmonary artery calcifications.
            disorders has not been critically evaluated. 446         Chest 2003;124:2093–7.
               Vitamin D metabolite treatment is gradually tapered  12. Anderson TE, Legendre AM, McEntee MM. Probable
            and then discontinued in patients with postsurgical hypo-  hypercalcemia of malignancy in a cat with bronchogenic
                                                                     adenocarcinoma. J Am Anim Hosp Assoc 2000;36:52–5.
            parathyroidism because hypocalcemia is usually transient.
                                                                  13. Andress DL. Vitamin D in chronic kidney disease: A sys-
            Most cats are able to maintain normal serum iCa          temic role for selective vitamin D receptor activation.
            concentrations 2 weeks after thyroidectomy, although     Kid Int 2006;69:33–43.
            some may take as long as 3 months. Dogs with hypocal-  14. Anthony LB, May ME, Oates JA. Case report: lanreotide
            cemia usually require 6 to 12 weeks of treatment after   in the management of hypercalcemia of malignancy. Am J
                                                                     Med Sci 1995;309:312–4.
            removal of a parathyroid gland adenoma. A reduction
                                                                  15. Arceneaux KA, Taboada J, Hosgood G. Blastomycosis in
            in dose of vitamin D metabolites is usually begun 1      dogs: 115 cases (1980-1995). J Am Vet Med Assoc
            month after initiation of therapy. If serum iCa concentra-  1998;213:658–64.
            tion declines substantially, the previous dose is resumed,  16. Aroch I, Ohad DG, Baneth G. Paresis and unusual electro-
            and reduction is attempted again 1 or 2 months later. Per-  cardiographic signs in a severely hypomagnesaemic,
                                                                     hypocalcaemic lactating bitch. J Small Anim Pract
            manent hypoparathyroidism is likely if failure to maintain
                                                                     1998;39:299–302.
            acceptable serum iCa concentration occurs after reduc-  17. Aroch I, Segev G, Klement E, et al. Fatal Vipera xanthina
            tion of the vitamin D metabolite dose at 3 months.       palestinae envenomation in 16 dogs. Vet Hum Toxicol
                                                                     2004;46:268–72.
                                                                  18. Atkins CE, Tyler R, Greenlee P. Clinical, biochemical,
            REFERENCES                                               acid-base, and electrolyte abnormalities in cats after hyper-
                                                                     tonic sodium phosphate enema administration. Am J Vet
                                                                     Res 1985;46:980–8.
              1. Abou-Samra AB, Juppner H, Force T, et al. Expression  19. Aubin JE, Heersche JN. Vitamin D and osteoblasts. In:
                cloning of a common receptor for parathyroid hormone  Feldman D, editor. Vitamin D. New York: Academic
                and parathyroid hormone-related peptide from rat osteo-  Press; 1997. p. 313–28.
                blast-like cells: a single receptor stimulates intracellular  20. Aucella F, Scalzulli RP, Gatta G, et al. Calcitriol increases
                accumulation of both cAMP and inositol triphosphates  burst-forming unit-erythroid proliferation in chronic
                and increases intracellular free calcium. Proc Natl Acad  renal failure; a synergistic effect with r-HuEpo. Nephron
                Sci USA 1992;89:2732–6.
                                                                     Clin Pract 2003;95:c121–7.
   183   184   185   186   187   188   189   190   191   192   193